BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5768784)

  • 1. Dextran anaphylaxis.
    Maddi VI; Wyso EM; Zinner EN
    Angiology; 1969 May; 20(5):243-8. PubMed ID: 5768784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal anaphylactoid reaction after dextran 40 administration.
    Flatau E; Resnitzky P
    JAMA; 1980 Mar; 243(10):1035-6. PubMed ID: 7354553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anaphylaxis after dextran 40 infusion: report of a case and review of the literature].
    Machado MA; Volpe P; Lima M das G; Mileo LF; Bocchini SF; Gama AH; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(4):167-9. PubMed ID: 7506840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of low-molecular dextran on plasma cholesterol level in patients with arteriosclerosis].
    Himmel A; Tkaczewski W; Walasek L
    Pol Tyg Lek; 1970 Jan; 25(2):43-5. PubMed ID: 5415359
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the therapy of peripheral organo-angiopathies using Progresin].
    Horn HJ
    Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dextran hypersensitivity and heart arrest].
    Recarte García-Andrade C; Muñoz Ruiz A; del Castillo Rueda A
    An Med Interna; 1993 Jul; 10(7):363-4. PubMed ID: 7692993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dextran and anaphylactic reaction].
    Lakartidningen; 1976 Apr; 73(15):1432-3. PubMed ID: 1263666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of dextran anaphylaxis].
    Laubenthal H; Peter K; Messmer K
    MMW Munch Med Wochenschr; 1982 Oct; 124(43):951-3. PubMed ID: 6183584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dextran-intolerance (author's transl)].
    Misgeld V; Mende C
    Med Klin; 1974 Sep; 69(36):1452-5. PubMed ID: 4140461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of anaphylactic shock due to a low molecular weight dextran].
    Sasaki T; Ito C; Ito K
    Masui; 1970 Feb; 19(2):215-7. PubMed ID: 5461314
    [No Abstract]   [Full Text] [Related]  

  • 15. [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].
    Sinitsyn VE; Veselova TN; Bakharev AO; Karpov IuA
    Ter Arkh; 1996; 68(12):69-72. PubMed ID: 9054047
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
    Zinderman CE; Landow L; Wise RP
    J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart arrest and shock caused by low molecular dextran (Rheomacrodex)].
    Schobinger RA
    Helv Chir Acta; 1970 Apr; 37(1):9-11. PubMed ID: 4107167
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.